Favorable Government Support Fuels Germany's Biotech Innovation and Commercialization: Market to Surpass USD 94 Billion by 2034 Led by QIAGEN, Thermo Fisher Scientific, Illumina and Roche
Dublin, July 18, 2025 (GLOBE NEWSWIRE) -- The "Germany Biotechnology Market Report and Forecast 2025-2034" has been added to ResearchAndMarkets.com's offering.The Germany biotechnology market was valued at USD 35.30 Billion in 2024, bolstered by robust public and private investment in biotech innovation, alongside significant R&D endeavors supported by established academic and research institutions. The market is expected to grow at a CAGR of 10.30% during 2025-2034, potentially reaching USD 94.09 Billion by 2034.
Government initiatives and funding play a critical role in accelerating the development and commercialization of advanced biotechnological solutions, contributing to market expansion. This growth is also underpinned by strong infrastructure, substantial R&D capabilities, and a skilled workforce. The increasing adoption of precision medicine and biopharmaceuticals is anticipated to further drive market growth in the forecast period.
Increasing Prevalence of Chronic Diseases
The market's growth is heavily influenced by the rising incidence of chronic and degenerative diseases. According to WHO data from 2021, conditions such as ischemic heart disease, Alzheimer's disease, stroke, various cancers, COPD, and kidney disorders impose a significant health burden, intensifying demand for innovative diagnostics, targeted therapies, and precision medicine. This drives forward the biotechnology sector, bolstered by increased research and development investments from both public and private sectors.
Germany Biotechnology Market Trends
Key trends include rising investments and the advent of cutting-edge, sustainable technologies. Investment confidence continues to grow, evidenced by a 78% increase in funding for German biotech firms, reaching EUR 1.917 billion in 2024, according to BIO Deutschland and EY. This capital influx is set to enhance market growth and technological progress.
Additionally, innovative, eco-friendly food technologies are driving demand. In March 2024, the launch of Kynda's zero-waste mycelium-based food product in Germany highlighted a move towards sustainable consumer solutions, anticipating an increase in the market's growth and the adoption of sustainable biotech products.
Germany Biotechnology Market Segmentation
The market analysis includes segments such as:
Product Type: Instruments, Reagents, Software and Services, Others
Technology: Nanobiotechnology, Tissue Engineering, DNA Sequencing, Cell-based Assays, Fermentation, PCR Technology, Chromatography, Others
Application: Health, Food & Agriculture, Natural Resources & Environment, Industrial Processing, Bioinformatics, Others
Germany Biotechnology Market Share: DNA Sequencing's Impact
The biotechnology market in Germany is diversified across various technologies, with DNA sequencing anticipated to lead. Innovations like Merck's Aptegra platform, which integrates multiple assays into one, significantly reduce testing times and costs, driving DNA sequencing's important role in the market's future growth.
Leading Players in the Germany Biotechnology Market
The major market players include:
QIAGEN N.V: Expanded its portfolio by acquiring Genoox, enhancing AI-driven genetic data interpretation for clinical decision-making.
Thermo Fisher Scientific, Inc: Introduced sustainable centrifuges in Germany, boosting energy efficiency in bioprocessing.
Illumina Inc: Partnered with Ovation.io to launch an extensive clinical multiomic dataset, propelling advancements in metabolic disease therapies.
F. Hoffman-La Roche Ltd: Gained FDA clearance for a dual mRNA probe assay improving B-cell lymphoma diagnostics.
Other key companies include Evotec SE, Bio-Rad Laboratories, Agilent Technologies, and BioNTech SE.
Key Questions Answered
What was the Germany biotechnology market value in 2024?
What is the forecast for 2025-2034?
What drives demand in the market?
How has the market performed historically, and future expectations?
What are the major trends and challenges?
Which product, technology, and application segments are expected to dominate?
Who are the key players?
Key Attributes
Report Attribute
Details
No. of Pages
250
Forecast Period
2025-2034
Estimated Market Value (USD) in 2025
$35.3 Billion
Forecasted Market Value (USD) by 2034
$94.09 Billion
Compound Annual Growth Rate
10.3%
Regions Covered
Germany
Key Topics Covered
1 Preface
1.1 Objectives of the Study
1.2 Key Assumptions
1.3 Report Coverage - Key Segmentation and Scope
1.4 Research Methodology
2 Executive Summary
3 Biotechnology Market Overview
3.1 Europe Biotechnology Market
3.2 Germany Biotechnology Market
4 Vendor Positioning Analysis
4.1 Key Vendors
4.2 Prospective Leaders
4.3 Niche Leaders
4.4 Disruptors
5 Germany Biotechnology Market Landscape
5.1 Germany Biotechnology Market: Developers Landscape
5.2 Germany Biotechnology Market: Product Landscape
6 Germany Biotechnology Market Dynamics
6.1 Market Drivers and Constraints
6.2 SWOT Analysis
6.3 PESTEL Analysis
6.4 Porter's Five Forces Model
6.5 Key Demand Indicators
6.6 Key Price Indicators
6.7 Industry Events, Initiatives, and Trends
6.8 Value Chain Analysis
7 Germany Biotechnology Market Segmentation (2018-2034)
7.1 By Product Type
7.2 By Technology
7.3 By Application
8 Regulatory Framework
9 Patent Analysis
10 Funding and Investment Analysis
11 Strategic Initiatives
12 Supplier Landscape
13 Germany Biotechnology Market - Distribution Model (Additional Insight)
14 Key Opinion Leaders (KOL) Insights (Additional Insight)
For more information about this report visit https://www.researchandmarkets.com/r/2dvmnn
About ResearchAndMarkets.comResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Attachment
German Biotechnology Market
CONTACT: CONTACT: ResearchAndMarkets.com Laura Wood,Senior Press Manager press@researchandmarkets.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./ CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
14 minutes ago
- Yahoo
Real Madrid ready to admit DEFEAT over Ibrahima Konate
Bubbling away in the background of a landmark Liverpool summer transfer window has been the saga of . The Reds under sporting director have been busy adding quality all over the pitch - with Florian Wirtz, Hugo Ekitike, Milos Kerkez, Jeremie Frimpong and Giorgi Mamardashvili all arriving. LFC x New Era Shop Now LFC Signed Merch Shop Now LFC x Titleist Shop Now But centre-back has been suggested as an area potentially in need of attention considering the contract situation revolving around Konate. The 26-year-old has got less than 12 months left on his current deal - expiring in June 2026. So far there has been no breakthrough over a new deal - with it earlier reported that the France defender would be seeking £200k per week to renew. Konate a priority Madrid target However those reports were superseded by ones stating that Konate had made up his mind and would DECLINE a renewal from the Reds. Liverpool, it was mooted, would be powerless to prevent Konate from running down his deal and joining Real Madrid for free in 2026. Only things are not working out that way. Madrid have got reason to believe that adding Konate as a new free transfer is not going to be as easy as they first thought. First came the reports from France declaring that Liverpool had made a new contract offer to Konate. Madrid plot Konate Plan B And while that offer has not been answered as yet, it was enough to scare the Madrid media into reporting that adding Konate was now tougher than ever. That's been followed up with a report in Defensa Central which states that Xabi Alonso is now activating Plan B as Konate slips from their grasp. 'Xabi Alonso is seriously considering the possibility of counting on Joan Martínez,' the report reads, adding that the Madrid academy graduate is now due a promotion. © IMAGO Madrid rolling back from Konate claims The reason for the 17-year-old being drafted into the first-team picture is increasing uncertainty over the fate of Konate. Madrid media are now rowing back from their previous claims that the Konate deal was all but done. That should give us an indication of how they feel Liverpool contract talks are going to go. Konate should take a look around at what Liverpool have added this summer and provided the club can match his demands he needs to commit his future long-term to the reigning Premier League title holders.
Fast Company
an hour ago
- Fast Company
Trump says he likes a strong dollar, but a weaker one is ‘good for inflation'
BY Listen to this Article More info 0:00 / 1:31 U.S. President Donald Trump said on Friday he liked a strong dollar but 'you make a hell of a lot more money' with a weaker one. 'So when we have a strong dollar, one thing happens: It sounds good. But you don't do any tourism. You can't sell tractors, you can't sell trucks, you can't sell anything,' Trump said at the White House before leaving on a trip to Scotland. 'It is good for inflation, that's about it.' The dollar index, which measures the greenback's strength against six major currencies, steadied on Friday after hitting two-week lows earlier in the week. It is still down roughly 10% over the six months Trump has been in office. Trump has often complained that dollar strength blunts U.S. export competitiveness and hurts U.S. manufacturing and jobs. Trump told reporters on Friday that manufacturers would be the first to benefit from a falling dollar, citing construction and mining equipment maker Caterpillar, whose shares have risen 16% over the last month. Japan and China fought for weaker currencies for decades and were able to dominate markets over the years, Trump said. 'Now it doesn't sound good, but you make a hell of a lot more money with a weaker dollar – not a weak dollar but a weaker dollar – than you do with a strong dollar,' he said. At the same time, he acknowledged that pushing for a weaker dollar wasn't a good look, saying a strong dollar is good psychologically. 'It makes you feel good,' he said. 'I love strong dollars.' —Steve Holland and Maiya Keidan, Reuters
UPI
an hour ago
- UPI
Wisconsin Lt. Gov. Sara Rodriguez launches gubernatorial bid
Wisconsin Lt. Gov. Sara Rodriguez is running for governor, the former emergency room nurse confirmed Friday. Photo courtesy of Governor of Wisconsin's office July 25 (UPI) -- Wisconsin Lt. Gov. Sara Rodriguez is running for governor, the former emergency room nurse confirmed Friday. "I'm used to being on my feet and getting right to the point, so let's go. First, I have an announcement. I'm running for governor," Rodriguez announced in a video released Friday, her 50th birthday. Rodriguez joins the Democratic primary field to replace Gov. Tony Evers, D-Wis. Evers, 73, announced in a video Thursday he would not seek re-election in November when he will turn 74. Evers has been the Governor of Wisconsin for six years and in public service for 50 years. Rodriguez is the first big name to enter the race to replace Evers. Milwaukee County Executive David Crowley confirmed Thursday to Spectrum News 1 Wisconsin that he plans to run. Former Wisconsin Lt. Gov. Mandela Barnes posted a photo of himself with Evers on X Thursday, thanking him for his service. Barnes served as lieutenant governor during Evers' first term and has hinted at a run for the office. Rodriguez previously worked in the emergency department of Baltimore's Mercy Medical Center. She later took a job at the U.S. Centers for Disease Control and Prevention between 2004 and 2006 before returning to Wisconsin. Increasing salaries for public teachers and expanding Medicaid access are among the promises Rodriguez makes in the video. "Look, we've got a real shot at flipping the state Legislature and with a Democratic governor, we can finally expand Medicaid and boost our healthcare workforce," Rodriguez says in the video, that also touches on her family's working-class roots in Wisconsin. "With a Democratic governor, we can finally expand Medicaid and boost our healthcare workforce, strengthen our farms, unions, and small businesses, fund our public schools and give teachers the raise they've earned. That's the right path."
